Latest Stories

Don’t miss our hot and upcoming stories
Will the European Commission’s New Health Policy Package Accelerate Biotech, AI, and Medical Device Innovation?

The European Commission has unveiled a new health policy package to strengthen innovation, competitiveness, and…

ByByAnuja Singh Dec 22, 2025
U.S. FDA Approves JASCAYD® for Progressive Pulmonary Fibrosis – A New Treatment Option for Adults?

Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has approved JASCAYD® (nerandomilast)…

ByByAnuja Singh Dec 22, 2025
Are Galux and Boehringer Ingelheim Pioneering AI in Precision Protein Design?

December 17, 2025 — Galux, a South Korean biotech company focused on AI-driven protein therapeutics,…

ByByAnuja Singh Dec 22, 2025
Has the FDA Approval of Breyanzi Expanded CAR T Cell Therapy Options for Marginal Zone Lymphoma Patients?

Bristol Myers Squibb has received approval from the U.S. Food and Drug Administration for Breyanzi,…

ByByAnuja Singh Dec 22, 2025
Scroll to Top